A 55-year-old Hispanic man, with a prior history of gastroesophageal reflux disease, fatty liver, and cholelithiasis, was evaluated in the emergency department with complaints of severe right upper quadrant pain that was triggered by food but not associated with any other gastrointestinal symptoms. One month prior, he had been evaluated by his primary care physician due to similar, but less severe and self-limited pain, undergoing an abdominal ultrasound that had revealed cholelithiasis without evidence of cholecystitis. At the time of admission to the hospital, he was afebrile and mildly icteric. His abdominal examination was notable for epigastric tenderness, without rebound or guarding. Laboratory tests were notable for a leukocytosis (17.3 K/μL) and mildly elevated serum liver enzyme concentrations (ALT 69 IU/L; bilirubin 3.2 mg/dL) (Figs. 1, 2). A repeat abdominal ultrasound was reported as showing no evidence of gallbladder wall thickening or acute changes of cholecystitis, but a dilated common bile duct (CBD) at 10.7 mm.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.